Jon Arnason Selected Research

Jon Arnason Research Topics

10	Neoplasms (Cancer) 11/2023 - 10/2012
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2024 - 05/2016
4	Lymphoma (Lymphomas) 12/2023 - 04/2018
3	Residual Neoplasm 02/2024 - 12/2016
3	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023 - 01/2022
3	Multiple Myeloma 11/2017 - 10/2012
2	Disease Progression 02/2024 - 08/2019
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 10/2010
2	Bronchiolitis Obliterans Syndrome 01/2023 - 01/2018
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2022 - 04/2018
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2021 - 04/2018
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 10/2017 - 07/2015
1	Neurotoxicity Syndromes (Toxic Encephalopathy) 11/2023
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 11/2023
1	Aortitis 12/2021
1	Giant Cell Arteritis (Horton Disease) 12/2021
1	Progressive Multifocal Leukoencephalopathy 10/2021
1	Cytopenia 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Diarrhea 01/2021
1	Hemorrhage 01/2020
1	Tenosynovitis 01/2020
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 08/2019
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2018
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2018
1	Myeloid Leukemia (Leukemia, Myelocytic) 11/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2016
1	Leukemia 12/2016
1	Autoimmune Diseases (Autoimmune Disease) 01/2007

5	Chimeric Antigen ReceptorsIBA 11/2023 - 01/2015
4	ibrutinibIBA 02/2024 - 05/2016
3	Rituximab (Mabthera)FDA Link 02/2024 - 01/2021
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 01/2021
3	fludarabineIBA 02/2024 - 01/2021
3	AntigensIBA 11/2017 - 10/2012
2	SteroidsIBA 01/2023 - 01/2018
2	Abatacept (Orencia)FDA Link 01/2023 - 01/2018
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 05/2016
2	tocilizumab (atlizumab)FDA Link 12/2021 - 10/2010
2	VaccinesIBA 11/2017 - 10/2012
2	Cancer VaccinesIBA 11/2017 - 12/2016
2	Mucin-1 (CA 15-3 Antigen)IBA 10/2017 - 07/2015
2	Monoclonal AntibodiesIBA 05/2016 - 10/2010
1	defibrotideIBA 11/2023
1	axicabtagene ciloleucelIBA 11/2023
1	duvelisibIBA 01/2022
1	PlatinumIBA 01/2022
1	venetoclaxIBA 01/2022
1	AnticoagulantsIBA 01/2020
1	4-toluenesulfonyl fluoride (TSF)IBA 01/2020
1	Alemtuzumab (Campath)FDA Link 01/2019
1	ofatumumab FDA Link 01/2019
1	Methylprednisolone FDA LinkGeneric 01/2019
1	XL765IBA 04/2018
1	Decitabine FDA Link 10/2017
1	Small Interfering RNA (siRNA)IBA 01/2015
1	LigandsIBA 01/2015
1	Lenalidomide (CC 5013)FDA Link 01/2013
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2007

14	Therapeutics 12/2023 - 10/2012
2	Immunotherapy 11/2023 - 10/2012
2	Drug Therapy (Chemotherapy) 01/2022 - 12/2016
2	Stem Cell Transplantation 01/2022 - 01/2018
2	Homologous Transplantation 01/2019 - 10/2012
1	Cell Transplantation 11/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2022
1	Transplantation 05/2016